Cargando…

EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England

Detalles Bibliográficos
Autores principales: Aballea, S, Karwala, P, Zerda, I, Toumi, M, Pochopien, M, Borissov, B, Clay, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232740/
http://dx.doi.org/10.1016/j.jval.2022.04.428
_version_ 1784735659374673920
author Aballea, S
Karwala, P
Zerda, I
Toumi, M
Pochopien, M
Borissov, B
Clay, E
author_facet Aballea, S
Karwala, P
Zerda, I
Toumi, M
Pochopien, M
Borissov, B
Clay, E
author_sort Aballea, S
collection PubMed
description
format Online
Article
Text
id pubmed-9232740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92327402022-06-27 EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England Aballea, S Karwala, P Zerda, I Toumi, M Pochopien, M Borissov, B Clay, E Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232740/ http://dx.doi.org/10.1016/j.jval.2022.04.428 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Aballea, S
Karwala, P
Zerda, I
Toumi, M
Pochopien, M
Borissov, B
Clay, E
EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title_full EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title_fullStr EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title_full_unstemmed EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title_short EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
title_sort ee179 key drivers of the economically justifiable price of the covid-19 vaccine in england
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232740/
http://dx.doi.org/10.1016/j.jval.2022.04.428
work_keys_str_mv AT aballeas ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT karwalap ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT zerdai ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT toumim ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT pochopienm ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT borissovb ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland
AT claye ee179keydriversoftheeconomicallyjustifiablepriceofthecovid19vaccineinengland